Common Contracts

DNA CANCER VACCINE COLLABORATION AND LICENSE AGREEMENT

Collaboration and License Agreement • April 16th, 2020

• Contract Type
  Collaboration and License Agreement
• Filed
  April 16th, 2020

by and between MedImmune, Limited with an office and place of business at Milstein Building, Granta Park, Cambridge CB21 6GH, United Kingdom (“MedImmune”) and Inovio Pharmaceuticals, Inc. with an office and place of business at 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462 U.S.A. (“Inovio”), on the other hand.

LICENSE AGREEMENT

Collaboration and License Agreement • April 16th, 2020 • Delaware

• Contract Type
  Collaboration and License Agreement
• Filed
  April 16th, 2020
• Jurisdiction
  Delaware

WHEREAS, Inovio has developed novel SynCon® DNA vaccine construct technology that may enable development of synthetic DNA vaccines targeted against, among other things, HPV-driven cancers (including the DNA vaccine known as INO-3112); and